143 related articles for article (PubMed ID: 9135497)
1. Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.
Wanderås EH; Fosså SD; Tretli S
Eur J Cancer; 1997 Feb; 33(2):253-62. PubMed ID: 9135497
[TBL] [Abstract][Full Text] [Related]
2. Secondary neoplasms following treatment of malignant germ cell tumors.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1993 Sep; 11(9):1703-9. PubMed ID: 8394879
[TBL] [Abstract][Full Text] [Related]
3. Second non-germ cell malignancies in patients treated for stage I-II testicular seminoma.
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Daly-Schveitzer N; Grosclaude P
Radiother Oncol; 1999 Feb; 50(2):191-7. PubMed ID: 10368043
[TBL] [Abstract][Full Text] [Related]
4. [Risk of second non-germ cell cancer after treatment of stage I-II testicular seminoma].
Bachaud JM; Berthier F; Soulié M; Malavaud B; Plante P; Rischmann P; Chevreau C; Grosclaude P
Prog Urol; 1999 Sep; 9(4):689-95. PubMed ID: 10555222
[TBL] [Abstract][Full Text] [Related]
5. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
[TBL] [Abstract][Full Text] [Related]
6. Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients.
Wanderås EH; Fosså SD; Tretli S
Eur J Cancer; 1997 Feb; 33(2):244-52. PubMed ID: 9135496
[TBL] [Abstract][Full Text] [Related]
7. Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.
van Leeuwen FE; Stiggelbout AM; van den Belt-Dusebout AW; Noyon R; Eliel MR; van Kerkhoff EH; Delemarre JF; Somers R
J Clin Oncol; 1993 Mar; 11(3):415-24. PubMed ID: 8445415
[TBL] [Abstract][Full Text] [Related]
8. Increased mortality rates in young and middle-aged patients with malignant germ cell tumours.
Fosså SD; Aass N; Harvei S; Tretli S
Br J Cancer; 2004 Feb; 90(3):607-12. PubMed ID: 14760372
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer.
Fosså SD; Aass N
Br J Urol; 1989 May; 63(5):531-4. PubMed ID: 2543475
[TBL] [Abstract][Full Text] [Related]
10. Treatment-associated leukemia following testicular cancer.
Travis LB; Andersson M; Gospodarowicz M; van Leeuwen FE; Bergfeldt K; Lynch CF; Curtis RE; Kohler BA; Wiklund T; Storm H; Holowaty E; Hall P; Pukkala E; Sleijfer DT; Clarke EA; Boice JD; Stovall M; Gilbert E
J Natl Cancer Inst; 2000 Jul; 92(14):1165-71. PubMed ID: 10904090
[TBL] [Abstract][Full Text] [Related]
11. Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.
Fosså SD; Langmark F; Aass N; Andersen A; Lothe R; Børresen AL
Br J Cancer; 1990 Apr; 61(4):639-43. PubMed ID: 2109999
[TBL] [Abstract][Full Text] [Related]
12. Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era.
Hellesnes R; Kvammen Ø; Myklebust TÅ; Bremnes RM; Karlsdottir Á; Negaard HFS; Tandstad T; Wilsgaard T; Fosså SD; Haugnes HS
Int J Cancer; 2020 Jul; 147(1):21-32. PubMed ID: 31597192
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.
Dueland S; Stenwig AE; Heilo A; Høie J; Ous S; Fosså SD
Br J Cancer; 1998; 77(2):329-35. PubMed ID: 9461006
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
15. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
16. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
[TBL] [Abstract][Full Text] [Related]
17. Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.
Miller RE; Markt SC; O'Donnell E; Bernard B; Albiges LK; Beard C; Sweeney CJ
Eur Urol Focus; 2017 Dec; 3(6):621-628. PubMed ID: 28753801
[TBL] [Abstract][Full Text] [Related]
18. Late effects of treatment for germ cell tumors during childhood and adolescence.
Hale GA; Marina NM; Jones-Wallace D; Greenwald CA; Jenkins JJ; Rao BN; Luo X; Hudson MM
J Pediatr Hematol Oncol; 1999; 21(2):115-22. PubMed ID: 10206457
[TBL] [Abstract][Full Text] [Related]
19. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
[TBL] [Abstract][Full Text] [Related]
20. Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study.
Al-Jebari Y; Glimelius I; Berglund Nord C; Cohn-Cedermark G; Ståhl O; Tandstad T; Jensen A; Sagstuen Haugnes H; Daugaard G; Rylander L; Giwercman A
PLoS Med; 2019 Jun; 16(6):e1002816. PubMed ID: 31163029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
